Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search
  1. NCI-F Publications

Search
  1. Year Published:

Your search returned 62 results.
User Information
Export Records
  1. 1.   Methotrexate-based PROTACs as DHFR-specific chemical probes
  2. Rana, Sandeep; Dranchak, Patricia; Dahlin, Jayme L; Lamy, Laurence; Li,Wenqing; Oliphant, Erin; Shrimp, Jonathan H; Rajacharya, Girish H; Tharakan, Ravi; Holland, David O; Whitten, Apryl S; Wilson, Kelli M; Singh, Pankaj K; Durum,Scott; Tao, Dingyin; Rai, Ganesha; Inglese, James
  3. Cell Chemical Biology. 2023, Oct 17;
  1. 2.   A Novel Biological Activity of the STAT3 Inhibitor Stattic in Inhibiting Glutathione Reductase and Suppressing the Tumorigenicity of Human Cervical Cancer Cells via a ROS-Dependent Pathway
  2. Xia, Yuchen; Wang, Guihua; Jiang, Manli; Liu, Xueting; Zhao, Yan; Song, Yinghui; Jiang, Binyuan; Zhu, Demao; Hu, Ling; Zhang, Zhao; Cao, Ting; Wang,Jiming; Hu, Jinyue
  3. OncoTargets and therapy. 2021, Jul 5; 14: 4047-4060.
  1. 3.   Dynamic Allostery: Linkers Are Not Merely Flexible
  2. Ma, B. Y.; Tsai, C. J.; Haliloglu, T.; Nussinov, R.
  3. Structure. 2011, Jul; 19(7): 907-917.
  1. 4.   High Dose Atorvastatin Decreases Cellular Markers of Immune Activation Without Affecting HIV-1 RNA Levels: Results of a Double-blind Randomized Placebo Controlled Clinical Trial
  2. Ganesan, A.; Crum-Cianflone, N.; Higgins, J.; Qin, J.; Rehm, C.; Metcalf, J.; Brandt, C.; Vita, J.; Decker, C. F.; Sklar, P.; Bavaro, M.; Tasker, S.; Follmann, D.; Maldarelli, F.
  3. Journal of Infectious Diseases. 2011, Mar; 203(6): 756-764.
  1. 5.   Discovery of a novel hybrid from finasteride and epristeride as 5 alpha-reductase inhibitor
  2. Yao, Z. Y.; Xu, Y. J.; Zhang, M. M.; Jiang, S.; Nicklaus, M. C.; Liao, C. Z.
  3. Bioorganic & Medicinal Chemistry Letters. 2011, Jan; 21(1): 475-478.
  1. 6.   A copper chelate of thiosemicarbazone NSC 689534 induces oxidative/ER stress and inhibits tumor growth in vitro and in vivo
  2. Hancock, C. N.; Stockwin, L. H.; Han, B. N.; Divelbiss, R. D.; Jun, J. H.; Malhotra, S. V.; Hollingshead, M. G.; Newton, D. L.
  3. Free Radical Biology and Medicine. 2011, Jan; 50(1): 110-121.
  1. 7.   Characterization of the Meiosis-Specific Recombinase Dmc1 of Pneumocystis
  2. Kutty, G.; Achaz, G.; Maldarelli, F.; Varma, A.; Shroff, R.; Becker, S.; Fantoni, G.; Kovacs, J. A.
  3. Journal of Infectious Diseases. 2010, Dec; 202(12): 1920-1929.
  1. 8.   Enzyme dynamics point to stepwise conformational selection in catalysis
  2. Ma, B. Y.; Nussinov, R.
  3. Current Opinion in Chemical Biology. 2010, Oct; 14(5): 652-659.
  1. 9.   Proline Metabolism and Microenvironmental Stress
  2. Phang, J. M.; Liu, W.; Zabirnyk, O.
  3. Annual review of nutrition. 2010, Aug 21; 30: 441-463.
  1. 10.   Natural product scaffolds as leads-to drugs
  2. Newman, D. J.; Cragg, G. M.
  3. Future Medicinal Chemistry. 2009, Nov; 1(8): 1415-1427.
  1. 11.   The role of dynamic conformational ensembles in biomolecular recognition
  2. Boehr, D. D.; Nussinov, R.; Wright, P. E.
  3. Nature Chemical Biology. 2009 5(11): 789-796.
  1. 12.   Structure Mechanism Insights and the Role of Nitric Oxide Donation Guide the Development of Oxadiazole-2-Oxides as Therapeutic Agents against Schistosomiasis
  2. Rai, G.; Sayed, A. A.; Lea, W. A.; Luecke, H. F.; Chakrapani, H.; Prast-Nielsen, S.; Jadhav, A.; Leister, W.; Shen, M.; Inglese, J.; Austin, C. P.; Keefer, L.; Arner, E.; Simeonov, A.; Maloney, D. J.; Williams, D. L.; Thomas, C. J.
  3. Journal of Medicinal Chemistry. 2009 52(20): 6474-6483.
  1. 13.   The lamin B receptor under transcriptional control of C/EBP epsilon is required for morphological but not functional maturation of neutrophils
  2. Cohen, T. V.; Klarmann, K. D.; Sakchaisri, K.; Cooper, J. P.; Kuhns, D.; Anver, M.; Johnson, P. F.; Williams, S. C.; Keller, J. R.; Stewart, C. L.
  3. Human Molecular Genetics. 2008 17(19): 2921-2933.
  1. 14.   MTHFR genotype and colorectal adenoma recurrence: Data from a double-blind placebo-controlled clinical trial
  2. Levine, A. J.; Wallace, K.; Tsang, S.; Haile, R. W.; Saibil, F.; Ahnen, D.; Cole, B. F.; Barry, E. L.; Munroe, D. J.; Ali, I. U.; Uel, P.; Baron, J. A.
  3. Cancer Epidemiology Biomarkers & Prevention. 2008 17(9): 2409-2415.
  1. 15.   One-carbon metabolism gene polymorphisms and risk of non-Hodgkin lymphoma in Australia
  2. Lee, K. M.; Lan, Q.; Kricker, A.; Purdue, M. P.; Grulich, A. E.; Vajdic, C. M.; Turner, J.; Whitby, D.; Kang, D.; Chanock, S.; Rothman, N.; Armstrong, B. K.
  3. Human Genetics. 2007, Dec; 122(5): 525-533.
  1. 16.   Selective restoration of the selenoprotein population in a mouse hepatocyte selenoproteinless background with different mutant selenocysteine tRNAs lacking Um34
  2. Carlson, B. A.; Moustafa, M. E.; Sengupta, A.; Schweizer, U.; Shrimali, R.; Rao, M.; Zhong, N.; Wang, S.; Feigenbaum, L.; Lee, B. J.; Gladyshev, V. N.; Hatfield, D. L.
  3. Journal of Biological Chemistry. 2007, Nov; 282(45): 32591-32602.
  1. 17.   Ligand binding and circular permutation modify residue interaction network in DHFR
  2. Hu, Z. J.; Bowen, D.; Southerl, W. M.; del Sol, A.; Pan, Y. P.; Nussinov, R.; Ma, B. Y.
  3. Plos Computational Biology. 2007, Jun; 3(6): 1097-1107.
  1. 18.   Data mining of NCI's anticancer screening database reveals mitochondrial complex I inhibitors cytotoxic to leukemia cell lines
  2. Glover, C. J.; Rabow, A. A.; Isgor, Y. G.; Shoemaker, R. H.; Covell, D. G.
  3. Biochemical Pharmacology. 2007, Feb; 73(3): 331-340.
  1. 19.   Intracellular nucleotides act as critical prosurvival factors by binding to cyctochrome c and inhibiting apoptosome
  2. Chandra, D.; Bratton, S. B.; Person, M. D.; Tian, Y. A.; Martin, A. G.; Ayres, M.; Fearnhead, H. O.; Gandhi, V.; Tang, D. G.
  3. Cell. 2006, Jun; 125(7): 1333-1346.
  1. 20.   The RIO kinases: An atypical protein kinase family required for ribosome biogenesis and cell cycle progression
  2. Laronde-Leblanc, N.; Wlodawer, A.
  3. Biochimica Et Biophysica Acta-Proteins and Proteomics. 2005, DEC 30; 1754(1-2, Sp. Iss.): 14-24.
  1. 21.   Ribonucleotide reductase and Cdc7 are important targets of HKH40A, a potent agent against gastrointestinal cancer
  2. Kosakowska-Cholody, T.; Monks, A. P.; Cholody, W. M.; Hariprakasha, H. K.; Kar, S.; Carr, B. I.; Michejda, C. J.
  3. Clinical Cancer Research. 2005, DEC 15; 11(24, Part 2 Suppl. S): 9016S-9016S.
  1. 22.   Isolation and characterization of novel cyclotides from Viola hederaceae - Solution structure and anti-HIV activity of vhl-1, a leaf-specific expressed cyclotide
  2. Chen, B.; Colgrave, M. L.; Daly, N. L.; Rosengren, K. J.; Gustafson, K. R.; Craik, D. J.
  3. Journal of Biological Chemistry. 2005, JUN 10; 280(23): 22395-22405.
  1. 23.   CYP1A1 Val(462) and NQO1 Ser(187) polymorphisms, cigarette use, and risk for colorectal adenoma
  2. Hou, L. F.; Chatterjee, N.; Huang, W. Y.; Baccarelli, A.; Yadavalli, S.; Yeager, M.; Bresalier, R. S.; Chanock, S. J.; Caporaso, N. E.; Ji, B. T.; Weissfeld, J. L.; Hayes, R. B.
  3. Carcinogenesis. 2005, JUN; 26(6): 1122-1128.
  1. 24.   Linking tumor cell cytotoxicity to mechanism of drug action: An integrated analysis of gene expression, small-molecule screening and structural databases
  2. Covell, D. G.; Wallqvist, A.; Huang, R. L.; Thanki, N.; Rabow, A. A.; Lu, X. J.
  3. Proteins-Structure Function and Bioinformatics. 2005, MAY 15; 59(3): 403-433.
  1. 25.   Elucidation of thioredoxin as a molecular target for antitumor quinols
  2. Bradshaw, T. D.; Matthews, C. S.; Cookson, J.; Chew, E. H.; Shah, M.; Bailey, K.; Monks, A.; Harris, E.; Westwell, A. D.; Wells, G.; Laughton, C. A.; Stevens, M. F. G.
  3. Cancer Research. 2005, MAY 1; 65(9): 3911-3919.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel